STRS Ohio’s Iovance Biotherapeutics IOVA Stock Holding History

STRS Ohio’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$89K	Buy	+21,400	New	+$81.3K	﹤0.01%	1896
2024 Q4	–	Sell	-9,900	Closed	-$93K	–	1964
2024 Q3	$93K	Sell	9,900 -2,100	-18%	-$19.9K	﹤0.01%	1717
2024 Q2	$96.2K	Buy	12,000 +1,200	+11%	+$12.9K	﹤0.01%	1707
2024 Q1	$160K	Buy	+10,800	New	+$126K	﹤0.01%	1604
2023 Q1	–	Sell	-20,200	Closed	-$129K	–	2000
2022 Q4	$129K	Hold	20,200	–	–	﹤0.01%	1685
2022 Q3	$193K	Sell	20,200 -4,700	-19%	-$54.2K	﹤0.01%	1611
2022 Q2	$274K	Buy	+24,900	New	+$326K	﹤0.01%	1506
2021 Q4	–	Sell	-105,000	Closed	-$2.59M	–	2252
2021 Q3	$2.59M	Sell	105,000 -50,000	-32%	-$1.18M	0.01%	600
2021 Q2	$4.03M	Hold	155,000	–	–	0.01%	534
2021 Q1	$4.91M	Buy	155,000 +140,353	+958%	+$5.82M	0.02%	497
2020 Q4	$679K	Sell	14,647 -2,096	-13%	-$83.2K	﹤0.01%	1297
2020 Q3	$551K	Sell	16,743 -2,168	-11%	-$66.5K	﹤0.01%	1268
2020 Q2	$519K	Sell	18,911 -113,289	-86%	-$3.72M	﹤0.01%	1285
2020 Q1	$3.96M	Buy	132,200 +800	+0.6%	+$21.2K	0.02%	431
2019 Q4	$3.64M	Buy	131,400 +3,600	+3%	+$81.9K	0.02%	534
2019 Q3	$2.33M	Buy	127,800 +900	+0.7%	+$19.9K	0.01%	626
2019 Q2	$3.11M	Buy	126,900 +6,900	+6%	+$104K	0.01%	558
2019 Q1	$1.14M	Buy	+120,000	New	+$1.17M	0.01%	773
2015 Q3	–	Sell	-14,400	Closed	-$112K	–	1912
2015 Q2	$132K	Buy	+14,400	New	+$161K	﹤0.01%	1637

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

STRS Ohio's IOVA Position: Q2 2026 in Review

STRS Ohio opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 21,400 shares worth $89K. The stake represents ﹤0.01% of the portfolio and ranks #1896 among its holdings. This is a return to the name: STRS Ohio previously reported a position in IOVA as recently as Q3 2024.

STRS Ohio first reported a position in IOVA in Q2 2015 and has held it in 19 quarters since. The position peaked at $4.91M in Q1 2021. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

STRS Ohio held 21,400 shares of Iovance Biotherapeutics worth $89K as of Q2 2026.
Iovance Biotherapeutics was a new STRS Ohio position in Q2 2026.
Iovance Biotherapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1896 holding.
STRS Ohio first reported a position in Iovance Biotherapeutics in Q2 2015 and has held it in 19 quarters since.
STRS Ohio's Iovance Biotherapeutics position peaked at $4.91M in Q1 2021.
292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.